Products
B2B Zone
8th MASH Drug Development Summit
8th MASH Drug Development Summit
Conferences

8th MASH Drug Development Summit

By

Hanson Wade

2 Followers
24 Sep 2024 - 26 Sep 2024
Free Registration

Event Details

8th MASH Drug Development Summit

Madrigal's blockbuster drug gaining FDA approval this March has opened the doors to a wave of therapeutics from Eli Lilly, Boehringer Ingelheim, AstraZeneca, Amgen, Akero Therapeutics and more that hold huge promise in Phase 1, 2, and 3 clinical trials. Paired with the boom of GLP-1s, these milestones have reinvigorated investment throughout the metabolic space.

The 8th MASH Drug Development Summit is the perfect forum to unite and discuss the evolving drug development opportunity for MASH and metabolic diseases. From optimizing clinical trial design to overcoming regulatory challenges, combatting fibrosis, navigating GLP-1 usage, optimizing RWE integration and achieving accurate non-invasive biomarkers, you won't find this industry-led insight anywhere else.

Join 120+ C-Level cardiometabolic stakeholders and thought leaders to make key connections, gain competitive insights and hear the latest data to shape the future of your MASH development pipeline.


URLs:
Website: https://go.evvnt.com/2611979-0?pid=10018
Tickets: https://go.evvnt.com/2611979-2?pid=10018
Brochure: https://go.evvnt.com/2611979-3?pid=10018

Prices:
Industry Pricing - Conference Only: USD 2999.00,
Industry Pricing - Conference + Clinical Workshop Day: USD 4197.00,
Industry Pricing - Conference + Pre-Clinical Workshop Day: USD 4197.00,
Vendor Pricing - Conference Only: USD 3699.00,
Vendor Pricing - Conference + Clinical Workshop Day: USD 5097.00,
Vendor Pricing - Conference + Pre-Clinical Workshop Day: USD 5097.00

Speakers: Adam Bell, Vice President, Neuraly, Bonnie Fendrock, Chief Executive Officer and Co-founder, Cyta Therapeutics, Charlotte Scott, Professor, Ghent University, Cynthia Arbeeny, CSO, Mitotherapeutix, David Brenner, Chief Executive Officer, Sanford Burnham Prebys, David Lloyd, Vice President, Insitro, Ezra Lowe, Vice President, Galectin Therapeutics, François Briand, Director - Research and Business Development, Physiogenex, Gerald Horan, Senior Scientific Director, Bristol Myers Squibb, Hank Mansbach, Chief Medical Officer, 89 Bio, Jay Kim, Chief Executive Officer, Therasid Bio, Jeff McIntyre. President, Global Liver Institute, Jerry Colca, Chief Scientific Officer, Cirius, Jingyu (Julia) Luan, Senior Director, AstraZeneca, Kai-Min Chu, Chief Executive Officer, Sinew, Katarina Wikstrom, Global VP Product Development, Almac, Kathleen Elias, Co-founder; Vice President - Research and Translational Medicine, Seal Rock Therapeutics, Kristin Fiorino, Medical Director, AstraZeneca, Lichuan Yang, Senior Director - Disease Model Development and Biomarkers, KBI, Manu Chakravarthy, SVP and Global Head of Cardiovascular, Renal and Metabolism Product Development, Carmot, Maria Trujillo, Senior Principal Scientist, Merck, Matt Bryant, Vice President, Boston Pharmaceuticals, Meena Bansal, Professor of Medicine, Mount Sinai, Michael Cooreman, Chief Medical Officer, Inventiva, Miriam Kidron, Chief Scientific Officer, Oramed, Oliver Yoa-Pu Hu, Professor, Taiwan University, Pitchumani Sivakumar, Director Translational Medicine, Pfizer, Rebecca Taub, Chief Medical Officer, Madrigal, Reshma Shringarpure, Vice President, Akero, Rosemarie Sellati, Director, Regeneron, Sarah Wills, Director, AstraZeneca, Scott Harris, Chief Medical Officer, Altimmune, Sherrie Pietranico Cole, Senior Director, Regeneron, Sophie Jeannin, Chief Medical Officer, Summit Clinical Research, Stephanie Watkins, Senior Director, Gilead, Tatiana Kisseleva, Associate Professor, University of California, Thomas Fabre, Senior Principal Scientist - Fibrosis, Pfizer, Yao-Yao Zhu, Director, Global Regulatory Affairs, AstraZeneca

Entry Fees

Free Registration

Categories

Event Frequency

One Time

Event Timings

(GMT-4:00) Eastern Time (US and Canada)
08:00 AM - 04:15 PM (Sep 24, Sep 25, Sep 26) (Public)

Speakers

Adam Bell
Adam Bell
Vice President, Neuraly
Bonnie Fendrock
Bonnie Fendrock
Chief Executive Officer and Co-founder, Cyta Therapeutics
Charlotte Scott
Charlotte Scott
Professor, Ghent University
Cynthia Arbeeny
Cynthia Arbeeny
CSO, Mitotherapeutix

Comments on 8th MASH Drug Development Summit

You must to write a comment.

Peoples Interested in Visit

0 Peoples Interested to Visit

Event Location

Hilton Boston Logan Airport
One Hotel Drive ,
Boston 02128, Massachusetts, United States
Official Link :

More Events By Organizer

Carbon Accounting in Agricultural Supply Chains
Carbon Accounting in Agricultural Supply Chains
12
Nov
2024
Free
Conferences
7th Lab Asset and Facility Management Summit
7th Lab Asset and Facility Management Summit
18
Nov
2024
Free
Conferences
2nd Covalent Drug Discovery and Development Summit
2nd Covalent Drug Discovery and Development Summit
10
Dec
2024
Free
Conferences
Raw Materials for Cell and Gene Therapy Summit
Raw Materials for Cell and Gene Therapy Summit
13
Nov
2024
Free
Conferences
Personalized Cancer Vaccine Summit
Personalized Cancer Vaccine Summit
03
Dec
2024
Free
Conferences
Cell and Gene Therapy Medical Affairs Summit
Cell and Gene Therapy Medical Affairs Summit
03
Dec
2024
Free
Conferences

Similar Events

Future of Technology Summit
Future of Technology Summit
20
Nov
2023

Future of Technology Summit

London, United Kingdom
Free
Conferences
GLOBAL ARTIFICIAL INTELLIGENCE SUMMIT and AWARDS
GLOBAL ARTIFICIAL INTELLIGENCE SUMMIT and AWARDS
18
Jan
2024
Free
Conferences
Cyber Next Summit, Saudi Edition
Cyber Next Summit, Saudi Edition
21
May
2024
Free
Conferences
The AI Summit New York 2023
The AI Summit New York 2023
06
Dec
2023

The AI Summit New York 2023

New York, United States
Free
Conferences
AI in Clinical R and D Summit
AI in Clinical R and D Summit
30
Nov
2022
Free
Conferences
Benefits of Signin
  • Publish Your Event for Free
  • Find Upcoming Events Near By
  • Grow Your B2B Network
  • Fix B2B Meeting Online/Event
  • Showcase Products to Right People